Role of docetaxel in the treatment of advanced gastric carcinoma
With a median survival of 9-11 months, advanced gastric cancer represents one of the most aggressive neoplastic disease in western Countries. Radical surgery is considered the cornerstone for any curative procedure, however only a relatively small proportion of resected cases can be considered cured...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SEEd
2009-03-01
|
| Saila: | Clinical Management Issues |
| Gaiak: | |
| Sarrera elektronikoa: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/557 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|